JAMA Network: Remote Symptom Monitoring With Electronic Patient-Reported Outcomes in Clinical Cancer Populations
In this nonrandomized controlled trial, hospitalizations were 19% and 13% lower among patients receiving RSM at 3 and 6 months, respectively. This nonrandomized controlled trial found that RSM implementation was associated with reduced risk of hospitalizations for patients with cancer, supporting the need to expand implementation nationally.
[embeddoc url=”https://connectwithcare.org/wp-content/uploads/2025/05/rocque_2025_oi_250357_1746551811.51675.pdf” download=”all”]